3-[allyl(1,2,3,4-tetrahydro-2-naphthalenyl)amino]-1-indanone | 1213711-87-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: 3-[allyl(1,2,3,4-tetrahydro-2-naphthalenyl)amino]-1-indanone
• 英文别名: 3-[Prop-2-enyl(1,2,3,4-tetrahydronaphthalen-2-yl)amino]-2,3-dihydroinden-1-one
• CAS: 1213711-87-5
• 化学式: C₂₂H₂₃NO
• 分子量: 317.431
• InChiKey: WSLAEHPEARLNKL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  24
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  20.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  丙烯酰碘 、 3-(1,2,3,4-tetrahydro-2-naphthalenylamino)-1-indanone 在 potassium carbonate 作用下， 以 丙酮 为溶剂， 以56%的产率得到3-[allyl(1,2,3,4-tetrahydro-2-naphthalenyl)amino]-1-indanone
  参考文献：
  名称：

  Synthesis and evaluation of dimeric 1,2,3,4-Tetrahydro-naphthalenylamine and Indan-1-ylamine derivatives with mast cell-stabilising and anti-allergic activity

  摘要：

  In a continuation of our studies into 4-Amino-3,4-dihydro-2H-naphthalen-1-ones as novel modulators of allergic and inflammatory phenomena, we have extended our work to include dimeric analogues. Of these derivatives, the most promising activity was seen with tertiary amine 58a, which exhibited potent mast cell-stabilising activity in vitro against a variety of stimuli and also in vivo against passive cutaneous anaphylaxis. (C) 2009 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2009.09.020

文献信息

• Synthesis and evaluation of dimeric 1,2,3,4-Tetrahydro-naphthalenylamine and Indan-1-ylamine derivatives with mast cell-stabilising and anti-allergic activity
  作者：James W. Barlow、John J. Walsh

  DOI：10.1016/j.ejmech.2009.09.020

  日期：2010.1

  In a continuation of our studies into 4-Amino-3,4-dihydro-2H-naphthalen-1-ones as novel modulators of allergic and inflammatory phenomena, we have extended our work to include dimeric analogues. Of these derivatives, the most promising activity was seen with tertiary amine 58a, which exhibited potent mast cell-stabilising activity in vitro against a variety of stimuli and also in vivo against passive cutaneous anaphylaxis. (C) 2009 Elsevier Masson SAS. All rights reserved.